Pharmaceutical White Papers - Pharmaceutical Business Review

Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential 08 December 2010 GBI Research, the leading business intelligence provider, has released its latest report, “Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential” that provides key data, information and analysis of the major trends and issues affecting the global nano-enabled drug delivery market. The report provides a comprehensive insight into the current and future application of nanotechnology in the drug delivery systems. It also provides an insight into the key drivers and barriers for the market growth. The report also provides a detailed analysis of the trends and its effects on the nano-enabled drug delivery market. The report also talks about the key regulations that affect the nanotechnology research and development and issues related to its use in pharmaceutical market. The report also details some case study of the latest technology being exploited in pharmaceutical industry. The report also provides detailed analysis of major deals that have happened in the nano-enabled drug delivery market landscape. At the end, the report looks into the future players. This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research’s team of industry experts. The nano-enabled drug delivery market has been a high growth market and expected to grow at a faster rate in the near future. According to a study conducted by Willi Paul, and Chandra P. Sharma, the nano-enabled drug delivery market was $1.7 billion in 2009 and expected to reach over $4.8 billion in 2012. The market will witness increased competition, high investment from venture capitalist and government. The M&A and Licensing landscape will see significant changes in the coming future. This is because market is expected to become more lucrative in coming future. The major drivers for the market growth are Increasing acceptance of nano-enabled drugs, and a strong pipeline portfolio. The increasing governmental funding and R&D interest will strengthen the market in future. However, lack of consistent policy on technology transfer, poor R&D facility, and tight audit control and lack of centralized system will restrain the market growth. The nano-enabled drug delivery market has strong pipeline. The pipeline is primarily dominated by molecules in early stage of development. This suggests that the there is high level of R&D investment. This will support the future market and will fuel the licensing activity. Reports Buy online from $3500

BioPharm Insight - Leading Insight and Pharmawire Intelligence BioPharm Insight provides the most comprehensive information to help you easily find the answers you need within the Biotechnology and Pharmaceutical industry. It includes the entire drug discovery and development pipeline, approved drugs, licensing deals, pharmaceutical sales/projections, management contacts, and more. Suppliers Randox - Biomarker Solutions for Clinical Trial Requirements Over the past 3 decades, Randox Pharma Services has been supplying the world’s leading CRO’s Pharmaceutical and Biotech companies and has built up unrivalled in-house technical know-how, whether in the development of new biomarker assays, companion diagnostics or the manufacture of the highest quality clinical diagnostic reagents and fully customised human and animal quality control sera and calibrators - That’s why our products are utilised by 60,000 customers in 130 countries! Suppliers Novasep - Integrated Manufacturing Solutions for Life Science Industries Novasep is a leading worldwide provider of integrated manufacturing solutions for the life science industries. We develop, market and operate innovative technologies from lab to industrial scale to produce biomolecules and synthetic molecules for the pharmaceutical, biopharmaceutical, agrochemical, fine chemical and industrial biotechnology markets. Suppliers INC Research - CRO for Drug and Device Development INC Research is a therapeutically focused global contract research organisation (CRO) with unrivaled expertise and a reputation for conducting global clinical development programs of the highest integrity. Suppliers

Production & Manufacturing Fine & Speciality Chemicals Manufacturing Process & Production OTC
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

White Papers Directory

Inside PBR

Report Store

Suppliers Directory